Background A progressive relationship between hemoglobin A 1c (HbA 1c) levels and
cardiovascular (CV) events has been observed in persons with and without diabetes. To our …

Objectives: This study was designed to examine the relationship between glycosylated
hemoglobin (HbA1C) and adverse outcomes in diabetic patients with established heart …

In patients with diabetes mellitus (DM) in the general population, elevated glycosylated
hemoglobin (HbA1c) increases the risk for developing heart failure (HF). However, in …

BACKGROUND: In diabetes, poor glycemic control, as indexed by hemoglobin A1c (HbA1c),
is associated with increased risk of cardiovascular events and new-onset heart failure (HF) …

Background—Among individuals without diabetes, elevated hemoglobin A1c (HbA1c) has
been associated with increased morbidity and mortality, but the literature is sparse regarding …

Background: Glycated haemoglobin (HbA1c) is an indicator of average blood glucose
concentrations over the preceding 3 months, is simpler to perform than either a fasting …

Background—Anemia is known to be a prognostic marker for patients with heart failure.
However, little is known about the prognostic value of changes in hemoglobin (Hgb) over …

Background The prognostic value of hemoglobin A1c (HbA1c) in coronary artery disease
(CAD) remains controversial. Herein, we conducted a systematic review to quantify the …

Aims/hypothesis The aim of this meta-analysis was to determine the relationship between
HbA 1c levels and subsequent cardiovascular outcomes in individuals without diabetes …

Background—We wished to determine the prevalence of, potential mechanistic associations
of, and clinical outcomes related to anemia in patients with heart failure and a broad …